PURPOSE: We tested the hypothesis that the M3 muscarinic acetylcholine receptor subtype mediates cholinergic responses in murine ophthalmic arteries after endothelial removal. METHODS: Muscarinic receptor gene expression was determined in ophthalmic arteries with intact and with removed endothelium using real-time PCR. To examine the role of the M3 receptor in mediating vascular responses, ophthalmic arteries from M3 receptor-deficient mice (M3R(-/-)) and respective wild-type controls were studied in vitro. Functional studies were performed in nonpreconstricted arteries with either intact or removed endothelium using video microscopy. RESULTS: In endothelium-intact ophthalmic arteries, mRNA for all five muscarinic receptor subtypes was detected, but M3 receptor mRNA was most abundant. In endothelium-removed ophthalmic arteries, M1, M2, and M3 receptors displayed similar mRNA expression levels, which were higher than those for M4 and M5 receptors. In functional studies, acetylcholine evoked vasoconstriction in endothelium-removed arteries from wild-type mice that was virtually abolished after incubation with the muscarinic receptor blocker atropine, indicative of the involvement of muscarinic receptors. In concentration-response experiments, acetylcholine and carbachol concentration-dependently constricted endothelium-removed ophthalmic arteries from wild-type mice, but produced only negligible responses in arteries from M3R(-/-) mice. In contrast, acetylcholine concentration-dependently dilated ophthalmic arteries with intact endothelium from wild-type mice, but not from M3R(-/-) mice. Responses to the nitric oxide donor nitroprusside and to KCl did not differ between ophthalmic arteries from wild-type and M3R(-/-) mice, neither in endothelium-intact nor in endothelium-removed arteries. CONCLUSIONS: These findings provide evidence that in murine ophthalmic arteries the muscarinic M3 receptor subtype mediates cholinergic endothelium-dependent vasodilation and endothelium-independent vasoconstriction.
PURPOSE: We tested the hypothesis that the M3 muscarinic acetylcholine receptor subtype mediates cholinergic responses in murine ophthalmic arteries after endothelial removal. METHODS: Muscarinic receptor gene expression was determined in ophthalmic arteries with intact and with removed endothelium using real-time PCR. To examine the role of the M3 receptor in mediating vascular responses, ophthalmic arteries from M3 receptor-deficient mice (M3R(-/-)) and respective wild-type controls were studied in vitro. Functional studies were performed in nonpreconstricted arteries with either intact or removed endothelium using video microscopy. RESULTS: In endothelium-intact ophthalmic arteries, mRNA for all five muscarinic receptor subtypes was detected, but M3 receptor mRNA was most abundant. In endothelium-removed ophthalmic arteries, M1, M2, and M3 receptors displayed similar mRNA expression levels, which were higher than those for M4 and M5 receptors. In functional studies, acetylcholine evoked vasoconstriction in endothelium-removed arteries from wild-type mice that was virtually abolished after incubation with the muscarinic receptor blocker atropine, indicative of the involvement of muscarinic receptors. In concentration-response experiments, acetylcholine and carbachol concentration-dependently constricted endothelium-removed ophthalmic arteries from wild-type mice, but produced only negligible responses in arteries from M3R(-/-) mice. In contrast, acetylcholine concentration-dependently dilated ophthalmic arteries with intact endothelium from wild-type mice, but not from M3R(-/-) mice. Responses to the nitric oxidedonornitroprusside and to KCl did not differ between ophthalmic arteries from wild-type and M3R(-/-) mice, neither in endothelium-intact nor in endothelium-removed arteries. CONCLUSIONS: These findings provide evidence that in murine ophthalmic arteries the muscarinic M3 receptor subtype mediates cholinergic endothelium-dependent vasodilation and endothelium-independent vasoconstriction.
Authors: Adrian Gericke; Marcin L Kordasz; Andreas Steege; Atsushi Sanbe; Evgeny Goloborodko; Jan M Vetter; Andreas Patzak; Norbert Pfeiffer Journal: Invest Ophthalmol Vis Sci Date: 2011-07-01 Impact factor: 4.799
Authors: Adrian Gericke; Jan J Sniatecki; Evgeny Goloborodko; Andreas Steege; Olga Zavaritskaya; Jan M Vetter; Franz H Grus; Andreas Patzak; Jürgen Wess; Norbert Pfeiffer Journal: Invest Ophthalmol Vis Sci Date: 2011-09-27 Impact factor: 4.799
Authors: Adrian Gericke; Jan J Sniatecki; Veronique G A Mayer; Evgeny Goloborodko; Andreas Patzak; Jürgen Wess; Norbert Pfeiffer Journal: Am J Physiol Heart Circ Physiol Date: 2011-02-18 Impact factor: 4.733
Authors: Adrian Gericke; Veronique G A Mayer; Andreas Steege; Andreas Patzak; Ulrike Neumann; Franz H Grus; Stephanie C Joachim; Lars Choritz; Jürgen Wess; Norbert Pfeiffer Journal: Invest Ophthalmol Vis Sci Date: 2009-04-30 Impact factor: 4.799
Authors: Thomas Münzel; Sebastian Steven; Katie Frenis; Johanna Helmstädter; Yue Ruan; Eva Schramm; Sanela Kalinovic; Swenja Kröller-Schön; Maria Teresa Bayo Jimenez; Omar Hahad; Matthias Oelze; Subao Jiang; Philip Wenzel; Clemens J Sommer; Katrin B M Frauenknecht; Ari Waisman; Adrian Gericke; Andreas Daiber Journal: Basic Res Cardiol Date: 2021-04-30 Impact factor: 17.165
Authors: Caroline Manicam; Julia Staubitz; Christoph Brochhausen; Franz H Grus; Norbert Pfeiffer; Adrian Gericke Journal: Sci Rep Date: 2016-02-02 Impact factor: 4.379
Authors: Elena Ivanova; Paola Bianchimano; Carlo Corona; Cyril G Eleftheriou; Botir T Sagdullaev Journal: Invest Ophthalmol Vis Sci Date: 2020-08-03 Impact factor: 4.799